Identification | Back Directory | [Name]
1-CHLOROH-PYRROLO[1,2-A]PYRAZINE | [CAS]
136927-64-5 | [Synonyms]
1-Chloro-1H-pyrrolo[1,2-a... 1-Chloropyrrolo[1,2-a]pyrazine 1-CHLOROH-PYRROLO[1,2-A]PYRAZINE Pyrrolo[1,2-a]pyrazine, 1-chloro- 1-Chloro-1H-pyrrolo[1,2-a]pyrazine | [Molecular Formula]
C7H5ClN2 | [MDL Number]
MFCD09839064 | [MOL File]
136927-64-5.mol | [Molecular Weight]
152.583 |
Hazard Information | Back Directory | [Uses]
1-Chloro-1H-pyrrolo[1,2-a]pyrazine is a pharmaceutical intermediate compound widely used in the pharmaceutical industry and laboratory research. | [Synthesis]
The general procedure for the synthesis of 1-chloropyrrolo[1,2-a]pyrazine from pyrrolo[1,2-a]pyrazin-1(2H)-one was as follows: pyrrolo[1,2-a]pyrazin-1(2H)-one (2.14 g, 16.0 mmol) was dissolved in phosphorus trichloride (20 mL), and the reaction was stirred for 16 h at room temperature. Upon completion of the reaction, the reaction mixture was quenched by slowly pouring it into ice water and neutralized with sodium bicarbonate solution. Subsequently, the aqueous phase was extracted several times with dichloromethane, and the combined organic phases were washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was removed by concentration under reduced pressure and the resulting residue was purified by silica gel column chromatography with 10% ethyl acetate/hexane as eluent to afford 1-chloropyrrolo[1,2-a]pyrazine (1.1 g, 45% yield). The structure of the product was analyzed by 1H NMR (500 MHz, CDCl3, δ: 7.62 (d, J = 4.5 Hz, 1H), 7.34 (dd, J = 2.5, 1.5 Hz, 1H), 7.12 (d, J = 4.5 Hz, 1H), 6.74-6.71 (m, 2H)), 13C NMR (125 MHz, CDCl3, δ. 154.4, 126.0, 125.6, 118.3, 117.4, 115.6, 105.2) and mass spectrometry (LRMS (ES): calculated value of C7H6ClN2 [M+1]+ 153, measured value of 153.2) confirmed. | [References]
[1] Journal of the American Chemical Society, 2006, vol. 128, # 48, p. 15372 - 15373 [2] Patent: WO2007/38387, 2007, A2. Location in patent: Page/Page column 80 |
|
|